BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32049296)

  • 1. Association of Infectious Diseases Consultation With Long-term Postdischarge Outcomes Among Patients With Staphylococcus aureus Bacteremia.
    Goto M; Jones MP; Schweizer ML; Livorsi DJ; Perencevich EN; Richardson K; Beck BF; Alexander B; Ohl ME
    JAMA Netw Open; 2020 Feb; 3(2):e1921048. PubMed ID: 32049296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.
    Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
    Clin Infect Dis; 2015 May; 60(10):1451-61. PubMed ID: 25701854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of infectious disease consultation on patients with Staphylococcus aureus bacteremia at a Japanese tertiary hospital: A retrospective observational study.
    Suzuki J; Sasahara T; Minami K; Morisawa Y; Yamada T
    J Infect Chemother; 2020 Aug; 26(8):780-784. PubMed ID: 32423701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
    Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
    JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Automated Telephone Infectious Disease Consultations to Nonacademic Hospitals on 30-Day Mortality Among Patients With Staphylococcus aureus Bacteremia: The SUPPORT Cluster Randomized Clinical Trial.
    Weis S; Hagel S; Palm J; Scherag A; Kolanos S; Bahrs C; Löffler B; Schmitz RPH; Rißner F; Brunkhorst FM; Pletz MW;
    JAMA Netw Open; 2022 Jun; 5(6):e2218515. PubMed ID: 35749114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study.
    Gotland N; Uhre ML; Mejer N; Skov R; Petersen A; Larsen AR; Benfield T;
    J Infect; 2016 Oct; 73(4):346-57. PubMed ID: 27418382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L; Harris MT; Brooks A; Main C; Mertz D
    BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
    Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
    Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
    Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review.
    Buehrle K; Pisano J; Han Z; Pettit NN
    Am J Infect Control; 2017 Jul; 45(7):713-716. PubMed ID: 28431847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia.
    Lahey T; Shah R; Gittzus J; Schwartzman J; Kirkland K
    Medicine (Baltimore); 2009 Sep; 88(5):263-267. PubMed ID: 19745684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study.
    Kawasuji H; Sakamaki I; Kawamura T; Ueno A; Miyajima Y; Matsumoto K; Kawago K; Higashi Y; Yamamoto Y
    J Infect Chemother; 2020 Jun; 26(6):588-595. PubMed ID: 32085966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of infectious diseases consultation in Staphylococcus aureus bacteremia.
    Honda H; Krauss MJ; Jones JC; Olsen MA; Warren DK
    Am J Med; 2010 Jul; 123(7):631-7. PubMed ID: 20493464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis.
    Vogel M; Schmitz RP; Hagel S; Pletz MW; Gagelmann N; Scherag A; Schlattmann P; Brunkhorst FM
    J Infect; 2016 Jan; 72(1):19-28. PubMed ID: 26453841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
    Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
    Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality of S. aureus bacteremia and infectious diseases specialist consultation--a study of 521 patients in Germany.
    Rieg S; Peyerl-Hoffmann G; de With K; Theilacker C; Wagner D; Hübner J; Dettenkofer M; Kaasch A; Seifert H; Schneider C; Kern WV
    J Infect; 2009 Oct; 59(4):232-9. PubMed ID: 19654021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
    Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
    Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
    Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.